✦ LIBER ✦

Thioridazine: Re-evaluating the Risk/Benefit Equation

✍ Scribed by Anna M. Timell

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Thioridazine: Re-evaluating the Risk

✍ Anna M. Timell 📂 Article 📅 2003 🏛 American Academy of Clinical Psychiatrists 🌐 English ⚖ 32 KB

D.B.C.P., Chlordecone, and the Risk-bene

✍ Khan, Samaira; Danko, John; Rosenberg, Samuel; Ahn, Jung Hwan 📂 Article 📅 1978 🏛 The Lancet 🌐 English ⚖ 290 KB

The risk-benefit equation: when to initi

✍ JI Robertson 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 863 KB

209 Re-evaluating the benefit of adjuvan

✍ T. Pickles; W. Kwan; M. Reed; P. Blood 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Evaluating the benefits and risks of pos

✍ Steven R. Cummings 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 677 KB

Evaluating the risk of patient re-identi

✍ El Emam, Khaled; Dankar, Fida K; Neisa, Angelica; Jonker, Elizabeth 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 435 KB